$132.83
+6.2%Nutex Health, Inc. operates as a technology-enabled healthcare services company. It operates through two divisions: Hospital division and Population Health Management division. The Hospital division implements and operates health care models, including micro-hospitals, specialty hospitals, and hospital outpatient departments. This division owns and operates 21 facilities in 8 states. The Population Health Management division owns and operates provider networks, such as independent physician associations. Its management services organizations provide management, administrative, and other support services to its affiliated hospitals and physician groups. This division's cloud-based proprietary technology platform aggregates data across multiple information systems, settings, and sources to create a holistic view of each patient and provider, as well as allows to deliver care. The company is based in Houston, Texas.
Chairman of the Board & Chief Executive Officer
Compensation
$1,081,214
Chief Financial Officer
Compensation
$652,832
Chief Legal Officer of Healthcare & Board Secretary
Compensation
$275,355
Chief Medical Officer
Chief Operating Officer
Compensation
$776,239
Director of Compliance
Director of Human Resources
Director of Marketing
Investor & Public Relations Manager
President & Director
Compensation
$1,182,269
During the last 12 months, insiders have purchased $148K worth of NUTX shares, with no selling activity reported.
491
45.70K
0
0.00
+46K
+$46K
0
0.00
0
0.00
+0
+$0
750
102.53K
0
0.00
+103K
+$103K
0
0.00
0
0.00
+0
+$0
Bates Jon Christian
Officer: Chief Financial Officer
$103K
Hosseinion Warren
Director, Officer: President
$24K
Jaumot Frank E
Director
$14K
Montgomery Pamela W.
Officer: Chief Legal Officer-Healthcare
$7K
Spears Kelvin
Director
$944
No selling activity
Strong bullish signal with $148K net buying. Insiders are aggressively accumulating shares, suggesting significant confidence in future prospects.
Perfect buy/sell ratio. Only buying activity with zero selling—the most bullish possible insider signal.
Very strong recent buying momentum. Recent insider purchases significantly outpace sales, suggesting near-term optimism.
5 insider buyers vs. 0 sellers. Broad-based buying across management team suggests widespread confidence.
Strong confluence of bullish signals: High buy/sell ratio, multiple insiders participating, and recent buying momentum all point to significant insider confidence. This level of coordinated buying often precedes positive developments.
NUTX - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
DEF 14A DEF 14A 2026 N/A | March 13, 2026 | March 13, 2026 | 2026 | |
DEF 14A DEF 14A 2025 N/A | June 02, 2025 | June 02, 2025 | 2025 | |
DEF 14A DEF 14A 2024 N/A | May 06, 2024 | June 17, 2024 | 2024 | |
DEF 14A DEF 14A N/A | May 19, 2023 | May 19, 2023 |
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.